54325 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 11
13:52 UTC
|
NIQ
NIQ Global Intelligence
|
◎ Target | Jason Haas not yet tracked | Overweight | $13.00→ $16.50+26.9% |
|
Aug 11
13:52 UTC
|
MRK
Merck & Co., Inc.
|
◎ Target | Jasper Hellweg ★★★★☆ #573 | Buy | $130.00→ $145.00+11.5% |
|
Aug 11
13:52 UTC
|
MNDY
monday.com
|
◎ Target | Ryan MacWilliams ★★★★★ #314 | Overweight | $130.00→ $120.00-7.7% |
|
Aug 11
13:52 UTC
|
MGX
Metagenomi
|
◎ Target | Yanan Zhu ★★☆☆☆ #2447 | Overweight | $7.00 |
|
Aug 11
13:52 UTC
|
MDLN
Medline
|
◎ Target | Stephen Baxter ★★★★★ #114 | Equal Weight | $45.00→ $34.00-24.4% |
|
Aug 11
13:52 UTC
|
MCK
McKesson
|
◎ Target | Stephen Baxter ★★★★★ #114 | Equal Weight | $812.00→ $933.00+14.9% |
|
Aug 11
13:52 UTC
|
LOW
Lowe's Companies
|
◎ Target | Zachary Fadem ★★★☆☆ #981 | Overweight | $255.00→ $245.00-3.9% |
|
Aug 11
13:52 UTC
|
LINC
Lincoln Educational Services
|
◎ Target | Steve Frankel ★★☆☆☆ #2295 | Buy | $60.00→ $50.00-16.7% |
|
Aug 11
13:52 UTC
|
HD
Home Depot
|
◎ Target | Zachary Fadem ★★★☆☆ #981 | Overweight | $360.00→ $400.00+11.1% |
|
Aug 11
13:52 UTC
|
GCMG
GCM Grosvenor
|
◎ Target | Crispin Love ★★★☆☆ #1112 | Overweight | $15.00→ $16.00+6.7% |
|
Aug 11
13:52 UTC
|
FERG
Ferguson
|
◎ Target | Sam Reid ★★★☆☆ #1169 | Overweight | $285.00→ $295.00+3.5% |
|
Aug 11
13:52 UTC
|
ETON
Eton Pharmaceuticals
|
◎ Target | Swayampakula Ramakanth ★★☆☆☆ #2769 | Buy | $57.00→ $65.00+14.0% |
|
Aug 11
13:52 UTC
|
COR
Cencora
|
◎ Target | Stephen Baxter ★★★★★ #114 | Overweight | $331.00→ $395.00+19.3% |
|
Aug 11
13:52 UTC
|
CON
Concentra Group Holdings Parent
|
◎ Target | Stephen Baxter ★★★★★ #114 | Overweight | $28.00→ $40.00+42.9% |
|
Aug 11
13:52 UTC
|
CEVA
Ceva
|
◎ Target | Martin Yang ★★★☆☆ #1832 | Outperform | $42.00→ $38.00-9.5% |
|
Aug 11
13:52 UTC
|
CATX
Perspective Therapeutics
|
◎ Target | Biren Amin ★☆☆☆☆ #3107 | Overweight | $16.00→ $14.00-12.5% |
|
Aug 11
13:52 UTC
|
BBY
Best Buy
|
◎ Target | Zachary Fadem ★★★☆☆ #981 | Equal Weight | $65.00→ $85.00+30.8% |
|
Aug 11
13:52 UTC
|
BBIO
BridgeBio Pharma
|
◎ Target | Derek Archila ★★★☆☆ #2202 | Overweight | $98.00→ $102.00+4.1% |
|
Aug 11
13:52 UTC
|
BBIO
BridgeBio Pharma
|
◎ Target | Biren Amin ★☆☆☆☆ #3107 | Overweight | $111.00→ $115.00+3.6% |
|
Aug 11
13:52 UTC
|
AXSM
Axsome Therapeutics
|
◎ Target | Benjamin Burnett ★★★☆☆ #1809 | Overweight | $255.00→ $256.00+0.4% |
|
Aug 11
13:52 UTC
|
ASTS
AST SpaceMobile
|
◎ Target | Alexander Potter ★☆☆☆☆ #3134 | Overweight | $100.00→ $98.00-2.0% |
|
Aug 11
13:52 UTC
|
AN
AutoNation
|
◎ Target | Bill Selesky ★★★☆☆ #1889 | Buy | $241.00→ $246.00+2.1% |
|
Aug 11
13:52 UTC
|
AAON
AAON
|
◎ Target | Noah Kaye ★★★☆☆ #2110 | Outperform | $145.00→ $125.00-13.8% |
|
Aug 11
13:52 UTC
|
TENX
Tenax Therapeutics
|
↓ Downgrade | firm only | Outperform→ In-Line | $5.00 |
|
Aug 11
13:52 UTC
|
BWMN
Bowman Consulting Group
|
↓ Downgrade | firm only | Hold | |
|
Aug 11
13:52 UTC
|
ALL
Allstate
|
↓ Downgrade | Matthew Heimermann ★★★★★ #72 | Neutral→ Sell | $240.00 |
|
Aug 11
13:52 UTC
|
P
Everpure
|
↑ Upgrade | Asiya Merchant ★★★☆☆ #1591 | Neutral→ Buy | $118.00 |
|
Aug 11
13:52 UTC
|
JBL
Jabil
|
↑ Upgrade | David Vogt ★★★☆☆ #1452 | Neutral→ Buy | $430.00 |
|
Aug 11
13:52 UTC
|
IPHA
Innate Pharma
|
↑ Upgrade | firm only | Market Perform→ Outperform | $4.00 |
|
Aug 11
13:52 UTC
|
CODI
Compass Diversified
|
↑ Upgrade | Timothy D'Agostino ★★★☆☆ #2086 | Neutral→ Buy | $11.00→ $15.00+36.4% |
|
Aug 11
13:52 UTC
|
CNC
Centene
|
↑ Upgrade | John Staszak ★★★☆☆ #2137 | Hold→ Buy | $80.00 |
|
Aug 11
13:52 UTC
|
CLBK
Columbia Financial
|
↑ Upgrade | Manuel Navas ★★★★☆ #479 | Neutral→ Overweight | $19.00→ $14.00-26.3% |
|
Aug 11
13:52 UTC
|
BA
Boeing
|
↑ Upgrade | Kristina Ruggeri ★★★★☆ #408 | Hold→ Buy | $265.00 |
|
Aug 11
12:52 UTC
|
WH
Wyndham Hotels & Resorts
|
◎ Target | Christopher Stathoulopoulos ★★★☆☆ #1058 | Neutral | $90.00→ $80.00-11.1% |
|
Aug 11
12:52 UTC
|
VOYA
Voya Financial
|
◎ Target | Ryan Krueger ★★★★★ #228 | Outperform | $109.00→ $110.00+0.9% |
|
Aug 11
12:52 UTC
|
UPWK
Upwork
|
◎ Target | Bernie McTernan ★★☆☆☆ #2560 | Buy | $15.00→ $11.00-26.7% |
|
Aug 11
12:52 UTC
|
TRVG
Trivago N.V. ADS
|
◎ Target | Lloyd Walmsley ★★★☆☆ #2164 | Neutral | $3.00→ $5.00+66.7% |
|
Aug 11
12:52 UTC
|
TGT
Target
|
◎ Target | Rupesh Parikh ★★★★☆ #540 | Outperform | $140.00→ $170.00+21.4% |
|
Aug 11
12:52 UTC
|
TCMD
Tactile Systems Technology
|
◎ Target | Ryan Zimmerman ★★★☆☆ #1519 | Buy | $40.00→ $39.00-2.5% |
|
Aug 11
12:52 UTC
|
SYRE
Spyre Therapeutics
|
◎ Target | Julian Harrison ★★☆☆☆ #2841 | Buy | $112.00→ $132.00+17.9% |
|
Aug 11
12:52 UTC
|
SNDA
Sonida Senior Living
|
◎ Target | Richard Anderson ★★★☆☆ #1425 | Overweight | $42.00→ $47.00+11.9% |
|
Aug 11
12:52 UTC
|
RPD
Rapid7
|
◎ Target | Shrenik Kothari ★★★★★ #43 | Neutral | $8.00→ $10.00+25.0% |
|
Aug 11
12:52 UTC
|
RKLB
Rocket Lab
|
◎ Target | Andres Sheppard ★☆☆☆☆ #3145 | Overweight | $96.00→ $122.00+27.1% |
|
Aug 11
12:52 UTC
|
RHP
Ryman Hospitality Properties
|
◎ Target | Jay Kornreich ★★★★☆ #825 | Overweight | $124.00→ $135.00+8.9% |
|
Aug 11
12:52 UTC
|
RDN
Radian Group
|
◎ Target | Bose George ★★★☆☆ #2182 | Outperform | $46.00→ $44.00-4.3% |
|
Aug 11
12:52 UTC
|
PRU
Prudential Financial
|
◎ Target | Ryan Krueger ★★★★★ #228 | Market Perform | $113.00→ $123.00+8.8% |
|
Aug 11
12:52 UTC
|
PRI
Primerica
|
◎ Target | Ryan Krueger ★★★★★ #228 | Market Perform | $323.00→ $335.00+3.7% |
|
Aug 11
12:52 UTC
|
PK
Park Hotels & Resorts
|
◎ Target | Jay Kornreich ★★★★☆ #825 | Neutral | $12.00→ $15.00+25.0% |
|
Aug 11
12:52 UTC
|
PEB
Pebblebrook Hotel Trust
|
◎ Target | Jay Kornreich ★★★★☆ #825 | Neutral | $15.00→ $19.00+26.7% |
|
Aug 11
12:52 UTC
|
PARR
Par Pacific
|
◎ Target | Nitin Kumar not yet tracked | Outperform | $80.00→ $85.00+6.2% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.